Professor Jennifer Walsh
MBChB, PhD, FRCP, SFHEA
School of Medicine and Population Health
Professor of Clinical Education
MBChB Programme Director
+44 114 215 9702
Full contact details
School of Medicine and Population Health
The Medical School
Beech Hill Road
Sheffield
S10 2RX
- Profile
-
For enquiries please contact - SMPH-West-Operational@sheffield.ac.uk
I trained in Endocrinology in Sheffield, and completed my PhD on Determinants of Peak Bone Mass and Bone Size.
My clinical practice is in metabolic bone disease, especially young adults.
I am Programme Director for the Sheffield MBChB.
- Research interests
-
My research interests are in bone pathophysiology and microarchitecture, skeletal maturation and ageing, the interactions of fat and bone, and treatment of osteoporosis and other metabolic bone diseases.
Current projects
- The effects of obesity on bone and muscle
- TOPaZ trial in osteogenesis imperfecta
- MOI-A losartan in osteogenesis imperfecta
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
- . The Lancet Healthy Longevity, 2(4), e212-e221.
- . PLOS Medicine, 16(11), ---.
- . The Journal of Clinical Endocrinology & Metabolism, 103(9), 3278-3288.
- . Osteoporosis International, 29(6), 1407-1417.
- . American Journal of Clinical Nutrition.
- . Journal of Bone and Mineral Research, 30(5), 920-928.
- . J Clin Endocrinol Metab, 98(7), 2902-2907.
- . J Clin Endocrinol Metab, 97(9), 3342-3348.
- . Arch Biochem Biophys, 503(1), 11-19.
- . Osteoporos Int, 20(3), 355-362.
- . J Clin Endocrinol Metab, 93(4), 1317-1323.
All publications
Journal articles
- . Advances in Therapy, 42(5), 2429-2444.
- . The American Journal of Clinical Nutrition, 120(5), 1019-1028.
- . Nutrients, 16(17).
- . Journal of Bone Oncology, 47.
- . Practical Neurology, 24(4), 289-295.
- . Frontiers in Bioengineering and Biotechnology, 12.
- . British Journal of Nutrition, 131(5), 901-910.
- . Proceedings of the Nutrition Society, 82(OCE5).
- . BMJ Open, 13(11).
- . Proceedings of the Nutrition Society, 82(OCE3).
- . Bone Reports, 18, 101676-101676.
- . RMD Open, 9(1).
- . Obesity, 31(2), 496-505.
- . The Journal of Frailty & Aging, 12(1), 37-42.
- . European Journal of Endocrinology, 187(6), 743-750.
- . Journal of Bone and Mineral Research, 37(11), 2165-2173.
- . Bone Reports, 16.
- . Osteoporosis International, 33(11), 2245-2257.
- . Osteoporosis International, 33(7), 1485-1491.
- . Osteoporosis International, 33(6), 1357-1363.
- . Archives of Osteoporosis, 17(1).
- . Journal of Cachexia, Sarcopenia and Muscle, 13(1), 68-85.
- . Osteoporosis International, 33(3), 737-744.
- . Journal of Medical Genetics, 59(8), 810-816.
- . Journal of Bone and Mineral Research, 36(6), 1048-1059.
- . Osteoporosis International, 32(5), 907-919.
- . Bone Reports, 14.
- . The Lancet Healthy Longevity, 2(4), e212-e221.
- . Efficacy and Mechanism Evaluation, 8(6).
- . Bone, 144.
- . Clinical Endocrinology, 94(1), 34-39.
- . European Journal of Endocrinology, 184(1), K7-K10.
- . Journal of Bone Oncology, 25.
- . Bone Reports, 13.
- . Bone Reports, 13.
- . Bone Reports, 13.
- . Bone Reports, 13.
- . Clinical Endocrinology, 93(2), 119-126.
- . Nutrients, 12(7).
- . Orphanet Journal of Rare Diseases, 15(1).
- . The Journal of Clinical Endocrinology & Metabolism, 105(4).
- . Osteoporosis International, 31(4), 667-675.
- . Bone, 131.
- . PLOS Medicine, 16(11), ---.
- . Osteoporosis International, 30(4), 917-922.
- . Bone, 121, 139-148.
- . Osteoporosis International, 30(1), 135-143.
- . Clinical Endocrinology, 90(1), 222-231.
- . The Journal of Clinical Endocrinology & Metabolism, 103(9), 3278-3288.
- . Osteoporosis International, 29(6), 1407-1417.
- . Osteoporosis International, 29(6), 1367-1378.
- . Journal of Clinical Endocrinology and Metabolism, 103(4), 1302-1309.
- . Nature Reviews Endocrinology, 14(5), 255-256.
- . European Journal of Endocrinology, 178(1), R19-R31.
- . Current Opinion in Endocrinology & Diabetes and Obesity, 24, 389-394.
- . Clinical Cases in Mineral and Bone Metabolism, 14(2), 173-178.
- . Bone, 99, 8-13.
- . Calcified Tissue International, 100(5), 528-535.
- . Surgery (United Kingdom), 36(1), 1-6.
- . Endocrine Connections, 5(5), G9-G11.
- . Annals of Clinical Biochemistry, 53(5), 554-560.
- . Bone, 92, 94-99.
- . American Journal of Clinical Nutrition.
- . Clinical Endocrinology, 84(2), 296-304.
- . Osteoporosis International.
- . Trials, 16(S2).
- . Trials, 16.
- . Journal of Bone and Mineral Research, 30(5), 920-928.
- . Surgery (Oxford), 33(1), 1-6.
- . Journal of Clinical Endocrinology & Metabolism, 100(2), 594-602.
- . Osteoporosis International, 25(12), 2729-2741.
- . Journal of Clinical Investigation, 124(2), 476-477.
- . Calcif Tissue Int, 94(2), 191-201.
- . Nat Rev Endocrinol, 9(11), 637-645.
- . Lancet, 382(9886), 5-7.
- . J Clin Endocrinol Metab, 98(7), 2902-2907.
- . J Clin Endocrinol Metab, 98(2), 519-521.
- . J Clin Endocrinol Metab, 97(9), 3342-3348.
- . Trends Endocrinol Metab, 23(4), 163-168.
- . Bone, 50(2), 457-466.
- . Clinical Endocrinology, 75(4), 443-449.
- . Bone, 49(1), 82-88.
- . Arch Biochem Biophys, 503(1), 11-19.
- . Bone, 47, S189-S190.
- . Clin Endocrinol (Oxf), 72(3), 320-327.
- . NAT REV ENDOCRINOL, 6(1), 10-12.
- . Fertil Steril, 93(3), 697-701.
- Effects of Feeding on Bone Metabolism. Clinical Reviews in Bone and Mineral Metabolism, 7(3), 230-239.
- . Osteoporos Int, 20(3), 355-362.
- . J Clin Endocrinol Metab, 93(4), 1317-1323.
- . Calcified Tissue International, 116(1).
- . Calcified Tissue International, 116(1).
- . Osteoporosis International.
- . Endocrine Abstracts.
- . Bone Abstracts.
- . Bone Abstracts.
- . Bone Abstracts.
Book chapters
- Metabolic complications In Young A, Board RE, Leonard P, Cooksley T, Stewart A & Michie C (Ed.), Problem Solving in Acute Oncology (pp. 84-88). ebn Health
- Metabolic Complications In Marshall E, Clark P, Selby P & Young A (Ed.), Problem Solving in Acute Oncology Clinical Publishing
Conference proceedings
- Patient reported outcomes (PROs) from a real-world study of burosumab treatment in adults with X-linked hypophosphatemia (XLH) in the UK. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 39 (pp 69-69)
- MOBILITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH PAEDIATRIC-ONSET HYPOPHOSPHATASIA TREATED WITH ASFOTASE ALFA: INTERIM ANALYSIS FROM THE UK MANAGED ACCESS AGREEMENT. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S45-S45)
- Bone turnover and bone balance in type 2 diabetes. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 312-312)
- Mobility and Health-related Quality of Life in Adults with Pediatric-onset Hypophosphatasia Treated With Asfotase Alfa: Interim Analysis From the UK Managed Access Agreement. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 12-12)
- . Journal of Bone and Mineral Research, Vol. 37(S1) (pp S271-S271). San Diego, California, 1 October 2021 - 1 October 2021.
- Association of Bone Turnover Markers and Advanced Glycation End Products in Type 1 Diabetes. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 79-79)
- RENAL SAFETY OF ZOLEDRONIC ACID IN PATIENTS WITH BORDERLINE KIDNEY FUNCTION AT A METABOLIC BONE CENTRE IN THE UK. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S194-S195)
- . Proceedings of the Nutrition Society, Vol. 80(OCE3) (pp e110). Online, 22 June 2021 - 22 June 2021.
- NORMOCALCEMIC HYPERPARATHYROIDISM: STUDY OF THE PREVALENCE AND NATURAL HISTORY. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S192-S192)
- Normocalcaemic hyperparathyroidism (NPHPT) and primary hyperparathyroidism (PHPT): Least significant change (LSC) for adjusted serum calcium. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 55-55)
- Bone Health in Type 1 Diabetes with and without Neuropathy; a Cross-Section Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 51-51)
- . Proceedings of the Nutrition Society, Vol. 79(OCE2) (pp e611). Dublin, Ireland, 15 October 2019 - 15 October 2019.
- . Annals of Oncology, Vol. 30(Suppl 5) (pp v334-v335). Barcelona, Spain, 27 September 2019 - 27 September 2019.
- THE CLINICAL UTILITY OF BONE FORMATION MARKERS TO MONITOR INTRAVENOUS ZOLEDRONATE TREATMENT. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp 620-620)
- NORMOCALCAEMIC HYPERPARATHYROIDISM: STUDY OF THE PREVALENCE AND NATURAL HISTORY IN A UNITED KINGDOM REFERRAL POPULATION. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp 627-627)
- Normocalcaemic Hyperparathyroidism: Study Of The Prevalence And Natural History In A United Kingdom Referral Population. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 129-129)
- Effect of high dose vitamin D on free 25(OH)D and ionised calcium in vitamin D-deficient postmenopausal women. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 400-400)
- Apparent Response Rate by PINP to Oral Bisphosphonates in Clinical Practice and Clinical Trial Settings. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 319-319)
- OSTEOPOROSIS IN YOUNG ADULTS: HOW TO INVESTIGATE AND WHEN TO TREAT. RHEUMATOLOGY, Vol. 57
- Offset of Effect of Oral Bisphosphonates on Tartrate-Resistant Acid Phosphatase in Postmenopausal Osteoporosis: the TRIO Study.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S379-S379)
- A meta-analysis of the risk of ankle and wrist fractures in diabetes.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S375-S376)
- NORMOCALCAEMIC HYPERPARATHYROIDISM: PREVALENCE IN A UNITED KINGDOM REFERRAL POPULATION. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp 649-650)
- A META-ANALYSIS OF THE RISK OF ANKLE AND WRIST FRACTURES IN DIABETES. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp 630-631)
- . Bone Abstracts, Vol. 5. Rome, Italy, 14 May 2016 - 14 May 2016.
- Serum 5-Hiaa - a Better Marker of Neuroendocrine Tumour Than Urine 5-Hiaa. ENDOCRINE REVIEWS, Vol. 35(3)
- Low Circulating 25 Hydroxyvitamin D in Obesity is not Associated with Lower 24-hour Urine Calcium, Higher Bone Turnover or Lower Bone Mineral Density. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 29 (pp S353-S353)
- LOW CIRCULATING 25 HYDROXYVITAMIN D IN OBESITY IS NOT ASSOCIATED WITH LOWER 24-HOUR URINE CALCIUM, HIGHER BONE TURNOVER OR LOWER BONE MINERAL DENSITY. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S672-S673)
- Vitamin D Status in Obesity: Evaluation of Free 25(OH)D. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
- THE EFFECTS OF GENDER AND OBESITY ON FRACTURE RISK AND CARDIOVASCULAR RISK. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S592-S593)
- THE EFFECT OF OBESITY ON BONE MINERAL DENSITY MEASURED AT FOUR FRACTURE SITES. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S525-S525)
- HIGH DOSE COLECALCIFEROL IN THE TREATMENT OF VITAMIN D DEFICIENCY. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S571-S571)
- HIGH CIRCULATING SEROTONIN IN CARCINOID SYNDROME IS NOT ASSOCIATED WITH ALTERATIONS IN BONE TURNOVER OR BONE DENSITY. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S536-S537)
- . Bone, Vol. 50 (pp S53-S53)
- Peak bone mineral content and bone volume at the lumbar spine in males and females: Longitudinal study.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21 (pp S206-S207)
- Endocrine determinants of bone turnover in adolescence and young adulthood.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21 (pp S206-S206)
- Effect of depot medroxyprogesterone acetate on markers of bone turnover.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 20(9) (pp S226-S226)
- Effect of depot medroxyprogesterone acetate on attainment of peak bone mass. BONE, Vol. 36 (pp S129-S129)
- Bone size at the distal radius is inversely correlated with volumetric bone mineral density. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S26-S26)
- Bone size at the distal radius is inversely correlated with volumetric bone mineral density.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 19 (pp S301-S301)
- Effect of depot medroxyprogesterone acetate on bone mineral density at the spine, hip and forearm.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S369-S369)
- . Bone Abstracts
Preprints
- .
- Research group
-
- Teaching interests
-
I completed the RCP/UCL Postgraduate Diploma in Medical Education in 2012
I am Programme Director of the undergraduate medicine degree. My teaching in the programme includes lectures and seminars on calcium physiology and metabolic bone disease.
I also lecture on several Masters programmes in the Faculty of Health.
I teach regularly on the ECTS PhD training course and Mellanby courses on bone biochemical markers and vertebral fracture.
I am a member of the RCP teaching team, and a tutor on the Doctors as Educators programme.
- Professional activities and memberships
-
- Royal Osteoporosis Society Clinical Advisor
- Brittle Bone Society Medical Board